Search results
Lexicon Pharmaceuticals (NASDAQ:LXRX) Upgraded to “Sell” by StockNews.com
ETF DAILY NEWS· 10 hours agoLexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) was upgraded by equities researchers at StockNews.com to a “sell” rating in a report issued on Wednesday. A number ...
Q1 2024 908 Devices Inc. Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 8 hours agoFurther, our Chief Product Officer, our VP of Government sales and I, along...management, commercial and technical teams have immense experience with optical spectroscopy ...
Stock Traders Purchase Large Volume of X4 Pharmaceuticals Put Options (NASDAQ:XFOR)
ETF DAILY NEWS· 9 hours agoX4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Get Free Report) saw unusually large options trading on Monday. Investors bought 2,515 put options on the company. This is an increase ...
Allspring Global Investments Holdings LLC Acquires 548 Shares of Ultragenyx Pharmaceutical Inc....
ETF DAILY NEWS· 1 day agoThe institutional investor owned 1,979 shares of the biopharmaceutical company’s stock after purchasing an additional 548 shares during the quarter. Allspring Global Investments Holdings < ...
Q1 2024 Eli Lilly and Co Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 hours agoResults...related to our strategic deliverables. Revenue grew 26% in Q1 with our new products growing nearly $1.8 billion compared with the same period last year. We achieved ...
Takeda Pharmaceutical Company Limited (NYSE:TAK) Shares Purchased by Lindbrook Capital LLC
ETF DAILY NEWS· 5 days agoLindbrook Capital LLC boosted its position in Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 40.6% in the 4th quarter, according to its ...
Citius Pharmaceuticals Announces $15 Million Registered Direct Offering
KSAN - KLST San Angelo· 5 days agoCitius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization ...
Q1 2024 Biomarin Pharmaceutical Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoResults may differ materially depending on the progress of BioMarin's product programs, actions of regulatory authorities, availability of capital, future actions in the & ...
Federated Hermes Inc. Sells 221,760 Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)
ETF DAILY NEWS· 1 day agoThe fund owned 102,500 shares of the company’s stock after selling 221,760 shares during the period. SG Americas Securities LLC lifted its position in Amylyx Pharmaceuticals ...
ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals
FOX21 Colorado Springs· 1 day agoONO Pharmaceutical, Co., Ltd., (TSE: 4528, Representative Director, Chairman of the Board and Chief Executive Officer: Gyo Sagara, "ONO") and Deciphera Pharmaceuticals ...
